Trials / Completed
CompletedNCT02523144
Dexmedetomidine in Children Having Transthoracic Echocardiography
A Qualitative Comparison of Oral Chloral Hydrate vs 2.0 or 3.0 mcg/kg Nasal Dexmedetomidine in Children Undergoing Transthoracic Echocardiography
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 279 (actual)
- Sponsor
- Children's Hospital Medical Center, Cincinnati · Academic / Other
- Sex
- All
- Age
- 3 Months – 36 Months
- Healthy volunteers
- Not accepted
Summary
Sedation Techniques for children undergoing transthoracic echocardiography (TTE).
Detailed description
The goal in this study is to determine if there is a significant difference in the quality of sedation between two standard sedation techniques and between two doses of dexmedetomidine for children undergoing (TTE).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chloral Hydrate | 70mg/kg chloral hydrate |
| DRUG | Dexmedetomidine | 2mcg/kg |
| DRUG | Dexmedetomidine | 3mcg/kg |
| DRUG | Placebo | Flavored placebo syrup |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2015-08-14
- Last updated
- 2017-07-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02523144. Inclusion in this directory is not an endorsement.